NCT02716012 2025-03-10
OUTREACH
Mina Alpha Limited
Phase 1 Unknown
Clinical Trials
712 trialsNCT06544083 2024-08-09
Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood
Second Affiliated Hospital, School of Medicine, Zhejiang University
Unknown
NCT06270706 2024-06-12
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Pliant Therapeutics, Inc.
Phase 1 Unknown
NCT06061445 2024-04-12
Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma
Fujian Cancer Hospital
Phase NA Unknown
NCT04780217 2024-03-04
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
ImmVira Pharma Co. Ltd
Phase 1/2 Unknown
NCT06289712 2024-03-04
EVALHEP
Assistance Publique - Hôpitaux de Paris
Unknown
NCT06285019 2024-02-29
Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma
Fudan University
Phase 2 Unknown
NCT06075849 2024-02-23
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Panolos Bioscience
Phase 1 Unknown
NCT05178043 2024-02-22
GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma
Suzhou Kintor Pharmaceutical Inc,
Phase 2 Unknown
NCT06210334 2024-02-20
HAI-TL
Eastern Hepatobiliary Surgery Hospital
Phase 2 Unknown
NCT06148155 2024-02-16
A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma
Huashan Hospital
Phase NA Unknown
NCT05842317 2024-02-09
Lenvatinib Plus Tislelizumab With or Without TACE in First-line Treatment of Unresectable HCC
Peking Union Medical College Hospital
Phase 1/2 Unknown
NCT05173298 2024-02-07
HCC
CHA University
Unknown
NCT06247293 2024-02-07
Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy
Zhujiang Hospital
Unknown
NCT06031818 2024-02-06
Usability and Clinical Effectiveness of an Interpretable Deep Learning Framework for Post-Hepatectomy Liver Failure Prediction
Maastricht University
Unknown
NCT04560894 2024-02-01
HCC
Sinocelltech Ltd.
Phase 2/3 Unknown
NCT04682847 2024-01-31
Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Unknown
NCT06233981 2024-01-31
Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT05062837 2024-01-23
Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC
Guangxi Medical University
Phase 2/3 Unknown
NCT05711823 2024-01-23
Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC
Guangxi Medical University
Phase 3 Unknown
NCT05910970 2024-01-23
PREVENT-2
Guangxi Medical University
Phase 3 Unknown
NCT04224480 2024-01-19
Longitudinal Immune-phenotyping of HCC Following MK-3475
National Cancer Centre, Singapore
Phase 1 Unknown
NCT04800497 2024-01-17
The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC
University of Milano Bicocca
Unknown
NCT05962450 2024-01-16
Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy
Beijing YouAn Hospital
Phase 2 Unknown
NCT06205732 2024-01-16
A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.
Qianfoshan Hospital
Unknown
NCT05021250 2024-01-10
SBRT With DIBH for HCC After TACE and Lipiodol Marking
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Unknown
NCT06144385 2024-01-02
A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
Shanghai Ming Ju Biotechnology Co., Ltd.
Phase 1 Unknown
NCT05718882 2023-12-28
Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC
RenJi Hospital
Phase NA Unknown
NCT06182865 2023-12-27
A Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton Therapy
National Atomic Research Institute, Taiwan
Phase NA Unknown
NCT04422249 2023-12-26
A Study of Laparoscopic Middle Hepatic Vein Guidance and Traditional Anatomic Hemihepatectomy
Southwest Hospital, China
Phase NA Unknown
NCT05031949 2023-12-19
CCGLC-003
Tongji Hospital
Phase 1 Unknown
NCT05103007 2023-12-19
CCGLC-004
Tongji Hospital
Phase NA Unknown
NCT05520801 2023-12-19
CCGLC-002
Tongji Hospital
Unknown
NCT05533892 2023-12-19
CCGLC-007
Tongji Hospital
Phase 1 Unknown
NCT04559607 2023-12-18
TACE Combined With Camrelizumab and Apatinib in Intermediate and Advanced Hepatocelluar Carcinoma
Zhongda Hospital
Phase NA Unknown
NCT03839706 2023-12-06
PETMRIinHCC
University Health Network, Toronto
Phase NA Unknown
NCT06134973 2023-11-22
A Prospective Study on the Application of Liquid Biopsy in the Surveillance of High-risk Population of HCC.
Tianjin Third Central Hospital
Unknown
NCT05609448 2023-11-18
EMERITUS-2
Radboud University Medical Center
Phase NA Unknown
NCT06101758 2023-10-26
SARCOLIVER
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Unknown
NCT06003673 2023-10-24
A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCC
First Affiliated Hospital of Fujian Medical University
Phase 4 Unknown
NCT06088459 2023-10-18
NWRD06 DNA Plasmid for HCC After Radical Resection
Newish Technology (Beijing) Co., Ltd.
Phase 1 Unknown
NCT06085976 2023-10-17
Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.
Clinica Universidad de Navarra, Universidad de Navarra
Phase 2 Unknown
NCT06086002 2023-10-17
Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma
Seoul National University Hospital
Phase NA Unknown
NCT04410302 2023-10-16
Patient-Derived Xenografts to Reduce Cancer Health Disparities
University of California, Davis
Unknown
NCT05250843 2023-10-13
TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC
Third Affiliated Hospital, Sun Yat-Sen University
Phase 2/3 Unknown
NCT04620538 2023-10-10
VOCAL
Imperial College London
Unknown
NCT06065592 2023-10-06
CAT_PB
Lebanese University
Phase 1 Unknown
NCT06070623 2023-10-06
Follow up After TACE by Elastography and Color Doppler.
Assiut University
Unknown
NCT05622136 2023-10-04
STRAT-aHCC
Instituto do Cancer do Estado de São Paulo
Phase 2 Unknown
NCT06042842 2023-10-04
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC
Assiut University
Unknown